DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories Limited
02 1TAPI Hungary Industries Kft.
03 1Glaxo Wellcome Manufacturing Pte. Ltd
04 1HIKAL LIMITED
05 1Hikma Pharmaceuticals
06 1Ipca Laboratories Limited
07 1SUN PHARMACEUTICAL INDUSTRIES, INC.
08 1ScinoPharm Taiwan Ltd.
09 1Teva Pharmaceutical Works Private Limited Company
01 1ONDANSETRON
02 6Ondansetron
03 1Ondansetron Hydrochloride
04 1ondansetron
01 4India
02 2Israel
03 1Taiwan
04 2United Kingdom
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-050
Start Marketing Date : 2010-01-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
NDC Package Code : 84671-1033
Start Marketing Date : 2017-11-17
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52482-019
Start Marketing Date : 2019-12-31
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66651-904
Start Marketing Date : 2015-01-23
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59115-807
Start Marketing Date : 2019-01-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 57451-1191
Start Marketing Date : 2010-08-18
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65129-2118
Start Marketing Date : 2004-11-19
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62756-469
Start Marketing Date : 2025-03-11
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51846-1033
Start Marketing Date : 2017-11-17
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
45
PharmaCompass offers a list of Ondansetron API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Ondansetron manufacturer or Ondansetron supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ondansetron manufacturer or Ondansetron supplier.
A QC-660 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of QC-660, including repackagers and relabelers. The FDA regulates QC-660 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. QC-660 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of QC-660 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A QC-660 supplier is an individual or a company that provides QC-660 active pharmaceutical ingredient (API) or QC-660 finished formulations upon request. The QC-660 suppliers may include QC-660 API manufacturers, exporters, distributors and traders.
click here to find a list of QC-660 suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing QC-660 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for QC-660 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture QC-660 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain QC-660 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a QC-660 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of QC-660 suppliers with NDC on PharmaCompass.
We have 9 companies offering QC-660
Get in contact with the supplier of your choice:
